XFLH Capital signs letter of intent to combine with Renogen Biolab
XFLH Capital entered into a Letter of Intent with Renogen Biolab for a proposed business combination, with due diligence access and efforts to negotiate definitive agreements.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
XFLH signs non-binding LOI to combine with Renogen Biolab
XFLH Capital Corporation signed a non-binding letter of intent to pursue a business combination with Renogen Biolab Inc. The companies plan to work toward definitive agreements and conduct mutual due diligence.